Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 5266 AL 5280

Kufor-Rakeb Syndrome in a Guatemalan Patient With an ATP13A2 Gene Pathogenic Variant: A Case Report

Méndez-Veras R, Urbizo A, Cabrera J, Boburg S.

Case Rep Genet. 2025 Nov 18;2025:6993134. doi: 10.1155/crig/6993134. eCollection 2025.

Editorial: Neuromuscular and kinematic dynamics in human movement adaptation

Singh RE, Davies JL, Purcell C.

Front Hum Neurosci. 2025 Nov 11;19:1724225. doi: 10.3389/fnhum.2025.1724225. eCollection 2025.

Multifunctionality of tissue inhibitor of metalloproteinase-1 in central nervous system diseases

Zhong L, Zhao L, Tang Q, Zhang X, Zhou M, Luo J, Wang Y.

Brain Res Bull. 2025 Dec;233:111647. doi: 10.1016/j.brainresbull.2025.111647. Epub 2025 Nov 25.

Proteostasis and pathogenesis: Unraveling the complexity of protein misfolding disorders

Nair T, Sarkar D, Murmu S, Singh Rawat R, Singha B.

Adv Protein Chem Struct Biol. 2025;148:299-353. doi: 10.1016/bs.apcsb.2025.08.013. Epub 2025 Oct 8.

Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook

Hajam IB, Ahanger IA, Rasool U, Dar TA.

Adv Protein Chem Struct Biol. 2025;148:379-453. doi: 10.1016/bs.apcsb.2025.08.017. Epub 2025 Sep 5.

Neurological letter from Canada

Furtado S.

Pract Neurol. 2025 Nov 27:pn-2024-004473. doi: 10.1136/pn-2024-004473. Online ahead of print.

There is not one Parkinson's disease, nor is there one cure

Bowen SJ.

NPJ Parkinsons Dis. 2025 Nov 27;11(1):339. doi: 10.1038/s41531-025-01183-w.

Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment

Poleur M, Gidaro T, Delstanche S, Gurruchaga JM, Tricot A, Bancel L, Palfi S, Servais L, Degos B.

Sci Rep. 2025 Nov 27;15(1):45479. doi: 10.1038/s41598-025-28927-1.

Identification of the efficacy and safety of apomorphine in the treatment of Parkinson's disease via meta-analysis

Li H, Zhang L, Jiang B, Jing L.

BMC Neurol. 2025 Nov 27;25(1):490. doi: 10.1186/s12883-025-04516-7.

COVID-19 vaccine-induced parkinsonism due to LGI1 antibody encephalitis: case report and brief literature review

Khabazeh A, Kumar J, Sheen V.

Oxf Med Case Reports. 2025 Nov 26;2025(11):omaf236. doi: 10.1093/omcr/omaf236. eCollection 2025 Nov.

Potential Mechanisms of Exercise-Mediated Ferroptosis Regulation in Central Nervous System Diseases

Li X, Guo Z, Li Q, Li C, Zhang X.

Mol Neurobiol. 2025 Nov 28;63(1):198. doi: 10.1007/s12035-025-05347-w.

Therapeutic prospects of modulating TLR4/MAPK/ROS signalling in obesity-associated neuroinflammation

Sharma D, Ravi RN, Abdullah ADI, Subramaniyan V.

Biomed Pharmacother. 2025 Dec;193:118805. doi: 10.1016/j.biopha.2025.118805. Epub 2025 Nov 27.

Biomarkers: From early detection to treatment personalization

Fatima S, Tiwari S, Siddiqi B, Quadri SN, Abdin MZ.

Prog Brain Res. 2025;297:131-153. doi: 10.1016/bs.pbr.2025.08.008. Epub 2025 Aug 25.

Multi-omics integration in disease research

Ceballos MWG, Sy FFA, Akbar A, Taofiq A.

Prog Brain Res. 2025;297:155-189. doi: 10.1016/bs.pbr.2025.08.012. Epub 2025 Aug 25.

Advanced neuroimaging in precision neurology: Tools, trends, and translational impact

Quadri SN, Tiwari S, Siddiqi B, Fatima S, Khan MA, Abdin MZ.

Prog Brain Res. 2025;297:221-246. doi: 10.1016/bs.pbr.2025.08.005. Epub 2025 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias